{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:53:37Z","timestamp":1790985217457,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nuclear receptors are key effectors of metabolic programs; however, the contribution of co-regulatory complexes in maintaining metabolic homeostasis is not fully understood. Here, we show that modulation of the constitutive androstane receptor (CAR) by the co-repressor silencing mediator of retinoic acid and thyroid hormone receptors (SMRT) is required for bile acid (BA) homeostasis. Transcriptional changes in the livers of mice harboring a targeted disruption in one of the nuclear receptor-interacting domains (RIDs), SMRT\n                    <jats:sup>mRID1<\/jats:sup>\n                    mice, revealed increased expression of CAR target genes involved in BA export. Consistent with this, SMRT\n                    <jats:sup>mRID1<\/jats:sup>\n                    mice challenged with a high-fat diet showed increased BAs in serum and urine with commensurate decreases in the liver and intestines. Notably, the reduction in intestinal BAs led to decreased activity of the BA receptor farnesoid X receptor (FXR). This reduction in FXR activity compromised the integrity of the intestinal barrier, increased bacterial burden, and augmented intestinal inflammation. Moreover, SMRT\n                    <jats:sup>mRID1<\/jats:sup>\n                    mice were susceptible to intestinal damage, with higher mortality rates in acute colitis and colitis-associated cancer models. Treatment with a synthetic FXR agonist (XL335) rescued SMRT\n                    <jats:sup>mRID1<\/jats:sup>\n                    mice during acute colitis. Collectively, these studies highlight the importance of SMRT in maintaining BA homeostasis through direct and indirect regulation of hepatic CAR and intestinal FXR activity, respectively, and point to potential therapeutic routes for combating intestinal pathologies associated with a high-fat diet.\n                  <\/jats:p>","DOI":"10.1038\/s12276-026-01823-y","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:22:54Z","timestamp":1788945774000},"page":"3088-3096","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMRT regulation of nuclear receptors orchestrates bile acid homeostasis"],"prefix":"10.1038","volume":"58","author":[{"given":"Kyeongkyu","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0201-5567","authenticated-orcid":false,"given":"Sungsoon","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Hyun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Jacinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6281-825X","authenticated-orcid":false,"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette R.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth T.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Liddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan L.","family":"Truitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7290-4304","authenticated-orcid":false,"given":"Chae Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-9585","authenticated-orcid":false,"given":"Michael","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9986-5965","authenticated-orcid":false,"given":"Ronald M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"1823_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.febslet.2007.11.016","volume":"582","author":"J Sonoda","year":"2008","unstructured":"Sonoda, J., Pei, L. & Evans, R. M. Nuclear receptors: decoding metabolic disease. FEBS Lett 582, 2\u20139 (2008).","journal-title":"FEBS Lett"},{"key":"1823_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1101\/gad.14.2.121","volume":"14","author":"CK Glass","year":"2000","unstructured":"Glass, C. K. & Rosenfeld, M. G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14, 121\u2013141 (2000).","journal-title":"Genes Dev"},{"key":"1823_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/377454a0","volume":"377","author":"JD Chen","year":"1995","unstructured":"Chen, J. D. & Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454\u2013457 (1995).","journal-title":"Nature"},{"key":"1823_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature06270","volume":"450","author":"K Jepsen","year":"2007","unstructured":"Jepsen, K. et al. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450, 415\u2013419 (2007).","journal-title":"Nature"},{"key":"1823_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0092-8674(00)80218-4","volume":"89","author":"L Nagy","year":"1997","unstructured":"Nagy, L. et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373\u2013380 (1997).","journal-title":"Cell"},{"key":"1823_CR6","doi-asserted-by":"publisher","first-page":"20021","DOI":"10.1073\/pnas.0811012105","volume":"105","author":"RR Nofsinger","year":"2008","unstructured":"Nofsinger, R. R. et al. SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis. Proc Natl Acad Sci USA 105, 20021\u201320026 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1823_CR7","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/nm.2450","volume":"17","author":"L Pei","year":"2011","unstructured":"Pei, L. et al. Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome. Nat Med 17, 1466\u20131472 (2011).","journal-title":"Nat Med"},{"key":"1823_CR8","doi-asserted-by":"publisher","first-page":"18820","DOI":"10.1073\/pnas.1318974110","volume":"110","author":"SH Hong","year":"2013","unstructured":"Hong, S. H. et al. Rescue of a primary myelofibrosis model by retinoid-antagonist therapy. Proc Natl Acad Sci USA 110, 18820\u201318825 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1823_CR9","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1073\/pnas.1017707108","volume":"108","author":"S Fang","year":"2011","unstructured":"Fang, S. et al. Corepressor SMRT promotes oxidative phosphorylation in adipose tissue and protects against diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 108, 3412\u20133417 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1823_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/hep.20784","volume":"42","author":"M Wagner","year":"2005","unstructured":"Wagner, M. et al. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42, 420\u2013430 (2005).","journal-title":"Hepatology"},{"key":"1823_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3760","volume":"21","author":"S Fang","year":"2015","unstructured":"Fang, S. et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med 21, 159\u2013165 (2015).","journal-title":"Nat Med"},{"key":"1823_CR12","doi-asserted-by":"publisher","first-page":"G774","DOI":"10.1152\/ajpgi.00387.2024","volume":"328","author":"J Jiang","year":"2025","unstructured":"Jiang, J. et al. Hepatic and intestinal tissue-specific Fxr deficiency alters bile acid homeostasis in female mice. Am J Physiol Gastrointest Liver Physiol 328, G774\u2013G790 (2025).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1823_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2012.02.012","volume":"15","author":"GD Barish","year":"2012","unstructured":"Barish, G. D. et al. The Bcl6-SMRT\/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell Metab 15, 554\u2013562 (2012).","journal-title":"Cell Metab"},{"key":"1823_CR14","doi-asserted-by":"publisher","first-page":"6318","DOI":"10.1128\/MCB.19.9.6318","volume":"19","author":"T Kawamoto","year":"1999","unstructured":"Kawamoto, T. et al. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19, 6318\u20136322 (1999).","journal-title":"Mol Cell Biol"},{"key":"1823_CR15","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1074\/jbc.274.10.6043","volume":"274","author":"T Sueyoshi","year":"1999","unstructured":"Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P. & Negishi, M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274, 6043\u20136046 (1999).","journal-title":"J Biol Chem"},{"key":"1823_CR16","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1128\/MCB.22.15.5270-5280.2002","volume":"22","author":"I Dussault","year":"2002","unstructured":"Dussault, I. et al. A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol Cell Biol 22, 5270\u20135280 (2002).","journal-title":"Mol Cell Biol"},{"key":"1823_CR17","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1073\/pnas.0509592103","volume":"103","author":"T Inagaki","year":"2006","unstructured":"Inagaki, T. et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci USA 103, 3920\u20133925 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1823_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","volume":"60","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta, R. M. et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60, 463\u2013472 (2011).","journal-title":"Gut"},{"key":"1823_CR19","doi-asserted-by":"publisher","first-page":"e23745","DOI":"10.1371\/journal.pone.0023745","volume":"6","author":"RM Nijmeijer","year":"2011","unstructured":"Nijmeijer, R. M. et al. Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease. PLoS ONE 6, e23745 (2011).","journal-title":"PLoS ONE"},{"key":"1823_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbagrm.2011.01.008","volume":"1809","author":"B Renga","year":"2011","unstructured":"Renga, B. et al. Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter. Biochim Biophys Acta 1809, 157\u2013165 (2011).","journal-title":"Biochim Biophys Acta"},{"key":"1823_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0955-0674(98)80014-8","volume":"10","author":"J Torchia","year":"1998","unstructured":"Torchia, J., Glass, C. & Rosenfeld, M. G. Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 10, 373\u2013383 (1998).","journal-title":"Curr Opin Cell Biol"},{"key":"1823_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cell.2011.10.017","volume":"147","author":"H Yamamoto","year":"2011","unstructured":"Yamamoto, H. et al. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147, 827\u2013839 (2011).","journal-title":"Cell"},{"key":"1823_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00215-1","volume":"8","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. RORalpha controls hepatic lipid homeostasis via negative regulation of PPARgamma transcriptional network. Nat Commun 8, 162 (2017).","journal-title":"Nat Commun"},{"key":"1823_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-025-02270-3","volume":"10","author":"P Jin","year":"2025","unstructured":"Jin, P. et al. Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions. Signal Transduct Target Ther 10, 228 (2025).","journal-title":"Signal Transduct Target Ther"},{"key":"1823_CR25","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1128\/iai.65.8.3126-3131.1997","volume":"65","author":"RJ Cahill","year":"1997","unstructured":"Cahill, R. J. et al. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 65, 3126\u20133131 (1997).","journal-title":"Infect Immun"},{"key":"1823_CR26","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank, D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104, 13780\u201313785 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"1823_CR27","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nature07008","volume":"453","author":"SK Mazmanian","year":"2008","unstructured":"Mazmanian, S. K., Round, J. L. & Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620\u2013625 (2008).","journal-title":"Nature"},{"key":"1823_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nri3228","volume":"12","author":"RL Gallo","year":"2012","unstructured":"Gallo, R. L. & Hooper, L. V. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol 12, 503\u2013516 (2012).","journal-title":"Nat Rev Immunol"},{"key":"1823_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0462-7","volume":"15","author":"X Zheng","year":"2017","unstructured":"Zheng, X. et al. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice. BMC Biol 15, 120 (2017).","journal-title":"BMC Biol"},{"key":"1823_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature11225","volume":"487","author":"S Devkota","year":"2012","unstructured":"Devkota, S. et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10\u2212\/\u2212 mice. Nature 487, 104\u2013108 (2012).","journal-title":"Nature"},{"key":"1823_CR31","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","volume":"68","author":"P Pathak","year":"2018","unstructured":"Pathak, P. et al. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology 68, 1574\u20131588 (2018).","journal-title":"Hepatology"},{"key":"1823_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17, 225\u2013235 (2013).","journal-title":"Cell Metab"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01823-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01823-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01823-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:02:21Z","timestamp":1790982141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01823-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01823-y","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}